ABO and preeclampsia: In view of the differential binding of PP13 to cell surfaces containing ABO blood group antigens, and its varying bioavailability in maternal blood depending on the ABO blood type, the adjustment of PP13 MoMs to ABO blood groups further improved their predictive value for preeclampsia as well as for IUGR and the two combined (21).